Diabetic and Hypertensive Heart Disease

Annals of Internal Medicine

Volumn 125, Issue 4, 1996, Pages 304-310

  Grossman, Ehud ^a   Messerli, Franz H ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; DIABETES MELLITUS; DISEASE MODEL; HEART DISEASE; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; REVIEW;

ANIMALS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; HEART DISEASES; HUMANS; HYPERTENSION;

EID: 0030586460     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-125-4-199608150-00009     Document Type: Review

References (100)

1. Five-year findings of the hypertension detection and follow-up program. II. Mortality by race-sex and age. Hypertension Detection and Follow-up Program Cooperative Group. JAMA. 1979;242:2572-7.
2. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol. 1974;34:29-34.
3. Factor SM, Minase T, Sonnenblick EH. Clinical and morphological features of human hypertensive-diabetic cardiomyopathy. Am Heart J. 1980;99: 446-58.
4. van Hoeven KH, Factor SM. A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease. Circulation. 1990;82:848-55.
5. Fein FS, Scheuer J. Heart disease in diabetes. In: Rifkin H, Porte D Jr, eds. Diabetes Mellitus: Theory and Practice. 4th ed. New York: Elsevier; 1990: 812-23.
6. Robertson WB, Strong JP. Atherosclerosis in persons with hypertension and diabetes mellitus. Lab Invest. 1968;18:538-51.
7. Hambly RI, Sherman L, Mehta J, Aintablian A. Reappraisal of the role of the diabetic state in coronary artery disease. Chest. 1976;70:251-7.
8. Waller BF, Palumbo PJ, Lie JT, Roberts WC. Status of the coronary arteries at necropsy in diabetes mellitus with onset after age 30 years. Analysis of 229 diabetic patients with and without clinical evidence of coronary heart disease and comparison to 183 control subjects. Am J Med. 1980;69: 498-506.
9. Herlitz J, Malmberg K, Karlson BW, Ryden L, Hjalmarson A. Mortality and morbidity during a five-year follow-up of diabetics with myocardial infarction. Acta Med Scand. 1988;224:31-8.
10. Orlander PR, Goff DC, Morrissey M, Ramsey DJ, Wear ML, Labarthe DR, et al. The relation of diabetes to the severity of acute myocardial infarction and post-myocardial infarction survival in Mexican-Americans and non-Hispanic whites. The Corpus Christi Heart Project. Diabetes. 1994;43: 897-902.
11. Kuusisto J, Mykkanen L, Pyorala K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes. 1994;43: 960-7.
12. Genuth S. Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus. Ann Intern Med 1996;124:104-9.
13. Elliott TG, Viberti G. Relationship between insulin resistance and coronary heart disease in diabetes mellitus and the general population: a critical appraisal. Bailliéres Clin Endocrinol Metab. 1993;7:1079-103.
14. MacRury SM, Lowe GD. Blood rheology in diabetes mellitus. Diabetic Med. 1990;7:285-91.
15. Giles TD, Sander GE. Myocardial disease in hypertensive-diabetic patients. Am J Med. 1989;87:23S-8S.
16. Ewing DJ, Campbell IW, Clarke BF. Mortality in diabetic autonomic neuropathy. Lancet. 1976;1:601-3.
17. Bellavere F, Ferri M, Guarini L, Bax G, Piccoli A, Cardone C, et al. Prolonged QT period in diabetic autonomic neuropathy: a possible role in sudden cardiac death? Br Heart J. 1988;59:379-83.
18. Ewing DJ, Boland O, Neilson JM, Cho CG, Clarke BF. Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients. Diabetologia. 1991;34:182-5
19. Nesto RW, Phillips RT, Kett KG, Hill T, Perper E, Young E, et al. Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: assessment by exercise thallium scintigraphy. Ann Intern Med. 1988; 108:170-5.
20. Ambepityia G, Kopelman PG, Ingram D, Swash M, Mills PG, Timmis AD. Exertional myocardial ischemia in diabetes: a quantitative analysis of anginal perceptual threshold and the influence of autonomic function. J Am Coll Cardiol. 1990;15:72-7
21. Niakan E, Harati Y, Rolak LA, Comstock JP, Rokey R. Silent myocardial infarction and diabetic cardiovascular autonomic neuropathy. Arch Intern Med. 1986;146:2229-30
22. Margolis JR, Kannel WS, Feinleib M, Dawber TR, McNamara PM. Clinical features of unrecognized myocardial infarction - silent and symptomatic. Eighteen year follow-up: the Framingham study. Am J Cardiol. 1973;32:1-7.
23. Cabin HS, Roberts WC. Quantitative comparison of extent of coronary narrowing and size of healed myocardial infarct in 33 necropsy patients with clinically recognized and in 28 with clinically unrecognized (silent) previous acute myocardial infarction. Am J Cardiol. 1982;50:677-81.
24. Factor SM, Bhan R, Minase T, Wolinsky H, Sonnenblick EH. Hypertensive-diabetic cardiomyopathy in the rat: an experimental model of human disease. Am J Pathol. 1981;102:219-28
25. D'Elia JA, Weinrauch L, Healy RW, Libertino JA, Bradley RF, Leland OS Jr. Myocardial dysfunction without coronary artery disease in diabetic renal failure. Am J Cardiol. 1979;43:193-9
26. Giacomelli F, Wiener J. Primary myocardial disease in the diabetic mouse. An ultrastructural study. Lab Invest. 1979;40:460-73.
27. Haider B, Ahmed SS, Moschos CB, Oldewurtel HA, Regan TJ. Myocardial function and coronary blood flow response to acute ischemia in chronic canine diabetes. Circ Res. 1977;40:577-83.
28. Hamby RI, Zoneraich S, Sherman L. Diabetic cardiomyopathy. JAMA. 1974;229:1749-54.
29. Regan TJ, Ettinger PO, Khan MI, Jesrani MU, Lyons MM, Oldewurtel HA, et al. Altered myocardial function and metabolism in chronic diabetes mellitus without ischemia in dogs. Circ Res. 1974;35:222-37.
30. Regan TJ, Ahmed SS, Levinson GE, Oldewurtel HA, Ahmad MR, Haider B, et al. Cardiomyopathy and regional scar in diabetes mellitus. Trans Assoc Am Phys. 1975;88:217-23.
31. Regan TJ, Lyons MM, Ahmed SS, Levinson GE, Oldewurtel HA, Ahmad MR, et al. Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest. 1977;60:884-99.
32. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972;30:595-602.
33. Sohar E, Ravid M, Ben-Shaul Y, Reshef T, Gafni J. Diabetic fibrillosis. A report of three cases. Am J Med. 1970;49:64-9.
34. Factor SM, Okun EM, Minase T. Capillary microaneurysms in the human diabetic heart. N Engl J Med. 1980;302:384-8.
35. Taegtmeyer H, Passmore JM. Defective energy metabolism of the heart in diabetes. Lancet. 1985;1:139-41.
36. Rosenthal T, Frohlich ED. Cardiac implications of hypertension and diabetes. Curr Opin Cardiol. 1993;8:746-56.
37. Allo SN, Lincoln TM, Wilson GL, Green FJ, Watanabe AM, Schaffer SW. Non-insulin-dependent diabetes-induced defects in cardiac cellular calcium regulation. Am J Physiol. 1991;260(6 pt 1):C1165-71.
38. Tanaka Y, Konno N, Kako KJ. Mitochondrial dysfunction observed in situ in cardiomyocytes of rats in experimental diabetes. Cardiovasc Res. 1992;26: 409-14.
39. Lee SL, Ostadalova I, Kolar F, Dhalla NS. Alterations in Ca(2+)-channels during the development of diabetic cardiomyopathy. Mol Cell Biochem. 1992; 109:173-9.
40. Ganguly PK, Pierce GN, Dhalla KS, Dhalla NS. Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am J Physiol. 1983; 244:E528-35.
41. Garber DW, Everett AW, Neely JR. Cardiac function and myosin ATPase in diabetic rats treated with insulin, T3, and T4. Am J Physiol. 1983;244: H592-8.
42. Malhotra A, Penpargkul S, Fein FS, Sonnenblick EH, Scheuer J. The effect of streptozotocin-induced diabetes in rats on cardiac contractile proteins. Circ Res. 1981;49:1243-50.
43. Penpargkul S, Fein F, Sonnenblick EH, Scheuer J. Depressed cardiac sarcoplasmic reticular function from diabetic rats. J Mol Cell Cardiol. 1981; 13:303-9.
44. Pierce GN, Dhalla NS. Cardiac myofibrillar ATPase activity in diabetic rats. J Mol Cell Cardiol. 1981;13:1063-9.
45. Noda N, Hayashi H, Miyata H, Suzuki S, Kobayashi A, Yamazaki N. Cytosolic Ca2+ concentration and pH of diabetic rat myocytes during metabolic inhibition. J Mol Cell Cardiol. 1992;24:435-6.
46. Rude RK. Magnesium deficiency and diabetes mellitus. Causes and effects. Postgrad Med. 1992;92:217-9, 222-4.
47. Schnider SL, Kohn RR. Glucosylation of human collagen in aging and diabetes mellitus. J Clin Invest. 1980;66:1179-81.
48. Schnider SL, Kohn RR. Effects of age and diabetes mellitus on the solubility and nonenzymatic glucosylation of human skin collagen. J Clin Invest. 1981; 67:1630-5.
49. Brownlee M, Vlassara H, Cerami A. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med. 1984;101:527-37.
50. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 1988;318:1315-21.
51. Fein FS, Sonnenblick EH. Diabetic cardiomyopathy. Prog Cardiovasc Dis. 1985;27:255-70.
52. Tahiliani AG, McNeill JH. Diabetes-induced abnormalities in the myocardium. Life Sci. 1986;38:959-74.
53. Dillmann WH. Diabetes mellitus induces changes in cardiac myosin of the rat. Diabetes. 1980;29:579-82.
54. Shapiro LM. Echocardiographic features of impaired ventricular function in diabetes mellitus. Br Heart J. 1982;47:439-44.
55. Borow KM, Jaspan JB, Williams KA, Neumann A, Wolinski-Walley P, Lang RM. Myocardial mechanics in young adult patients with diabetes mellitus: effects of altered load, inotropic state and dynamic exercise. J Am Coll Cardiol. 1990;15:1508-17.
56. Perez JE, McGill JB, Santiago JV, Schechtman KB, Waggoner AD, Miller JG, et al. Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease. J Am Coll Cardiol. 1992;19:1154-62.
57. Mustonen JN, Uusitupa MI, Laakso M, Vanninen E, Lansimies E, Kuikka JT, et al. Left ventricular systolic function in middle-aged patients with diabetes mellitus. Am J Cardiol. 1994;73:1202-8.
58. Iwasaka T, Sugiura T, Abe Y, Karakawa M, Matsui Y, Wakayama Y, et al. Residual left ventricular pump function following acute myocardial infarction in postmenopausal diabetic women. Coron Artery Dis. 1994;5: 237-42
59. Iwasaka T, Takayama Y, Izuoka T, Takehana K, Sugiura T, Matsui Y, et al. Effect of ventriculoarterial coupling on residual left ventricular pump function in diabetic patients with myocardial infarction. Cardiology. 1994;85:1-7.
60. Hoffman JI. A critical view of coronary reserve. Circulation. 1987;75(1 Pt 21:16-11.
61. Strauer BE. Myocardial oxygen consumption in chronic heart disease: role of wall stress, hypertrophy and coronary reserve. Am J Cardiol 1979;44: 730-40.
62. Chobanian AV, Brecher PI, Haudenschild CC. Effects of hypertension and antihypertensive therapy on atherosclerosis: state of the heart lecture. Hypertension 1986;8(Suppl 1):115-21.
63. Brush JE Jr, Cannon RO 3d, Schenke WH, Bonow RO, Leon MB, Maron BJ, et al. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med. 1988; 319:1302-7.
64. Tomanek RJ. The role of prevention or relief of pressure overload on the myocardial cell of the spontaneously hypertensive rat: a morphometric and stereologic study. Lab Invest 1979;40:83-91.
65. Marcus ML, Harrison DG, Chilian WM, Koyanagi S, Inou T, Tomanek RJ, et al. Alterations in the coronary circulation in the hyperttophied ventricles. Circulation. 1987;75(Suppl 1):119-25.
66. Duncker DJ, Zhang J, Bache RJ. Coronary pressure-flow relation in left ventricular hypertrophy. Importance of changes in back pressure versus changes in minimum resistance. Circ Res. 1993;72:579-87.
67. Kannel WB, Dannenberg AL, Abbott RD. Unrecognized myocardial infarction and hypertension: the Framingham study. Am Heart J. 1985;109(3 Pt 1):581-5.
68. O'Kelley BF, Tubau JF, Szlahcic J, Daiss K, Massie BM. Detection of silent coronary artery disease in hypertensive patients [Abstract]. Hypertension. 1988;12:344.
69. Dunn FG, Pringle SD. Left ventricular hypertrophy and myocardial ischemia in systemic hypertension. Am J Cardiol, 1987;60:191-221.
70. Drayer JI, Gardin JM, Brewer DD, Weber MA. Disparate relationships between blood pressure and left ventricular mass in patients with and without left ventricular hypertrophy. Hypertension. 1987;9(2 Pt 2):II61-4.
71. Frohlich ED, Apstein C, Chobanian AV, Devereux RB, Dustan HP, Dzau V, et al. The heart in hypertension. N Engl J Med 1992;327:998-1008.
72. Weber KT, Brilla CG, Janicki JS. Signals for the remodeling of cardiac interstitium in systemic hypertension. J Cardiovasc Pharmacol. 1991; 17(Suppl 2):S14-9.
73. Mercadier JJ, Lompre AM, Wisnewsky C, Samuel JL, Bercovki J, Swynghedauw B, et al. Myosin isoenzyme changes in several models of rat cardiac hypertrophy. Circ Res. 1981;49:525-32.
74. Grossman E, Oren S, Messerli FH. Left ventricular mass and cardiac function in patients with essential hypertension. J Hum Hypertens. 1994;8: 417-21.
75. Inouye I, Massie B, Loge D, Topic N, Silverstein D, Simpson P, et al. Abnormal left ventricular filling: an early finding in mild to moderate systemic hypertension. Am J Cardiol. 1984;53:120-6.
76. Devereux RB. Left ventricular diastolic dysfunction: early diastolic relaxation and late diastolic compliance. J Am Coll Cardiol. 1989;13:337-9.
77. Phillips RA, Goldman ME, Ardeljan M, Arora R, Elson HB, Yu BY, et al. Determinants of abnormal left ventricular filling in early hypertension. J Am Coll Cardiol. 1989;14:979-85.
78. Grossman E, Oren S, Messerli FH. Left ventricular filling and stress response pattern in essential hypertension. Am J Med. 1991;91:502-6.
79. Kannel WB, Castelli WP, McNamara PM, McKee PA, Feinleib M. Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med. 1972;287:781-7.
80. Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. Ann Intern Med. 1969;71:89-105.
81. Kreger BE, Kannel WB, Cupples LA. Electrocardiographs precursors of sudden unexpected death: the Framingham Study. Circulation. 1987;75(3 Part 2):II22-4.
82. Kannel WB. Prevalence and natural history of electrocardiographic left ventricular hypertrophy. Am J Med. 1983;75:4-11.
83. Messerli FH, Ventura HO, Elizardi DJ, Dunn FG, Frohlich ED. Hypertension and sudden death. Increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med. 1984;77:18-22.
84. McLenachan JM, Henderson E, Morris KI, Dargie HJ. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med. 1987;317:787-92.
85. Levy D, Anderson KM, Savage DD, Balkus SA, Kannel WB, Castelli WP. Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol. 1987;60:560-5.
86. Barnett AH. Diabetes and hypertension. 8r Med Bull. 1994;50:397-407.
87. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-607.
88. Assmann G, Schulte H. The Prospective Cardiovascular Munster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J 1988;116(6 Pt 2):1713-24.
89. Samuelsson O, Hedner T, Persson B, Andersson O, Berglund G, Wilhelmesen L. The role of diabetes mellitus and hypertriglyceridaemia as coronary risk factors in treated hypertension: 15 years of follow-up of anti-hypertensive treatment in middle-aged men in the Primary Prevention Trial in Goteberg, Sweden. J Intern Med. 1994;235:217-27.
90. Fernandez-Britto JE, Bacallao J, Castillo JA, Campos R, Wong R, Guski H. Atherosclerosis in diabetes and hypertension. A comparative morphometric study of their progression using an atherometric system. Zentralbl Pathol. 1991;137:487-91.
91. Arora GD, Reeves WC, Movahed A. Alteration of coronary perfusion reserve in hypertensive patients with diabetes. J Hum Hypertens. 1994;8: 51-7.
92. Melina D, Colivicchi F, Melina G, Pristipino C. Prevalence of silent ST segment depression during long-term ambulatory electrocardiographic monitoring in asymptomatic diabetic patients with essential hypertension. Minerva Med. 1993;84:301-5.
93. Venco A, Grandi A, Barzizza F, Finardi G. Echocardiographic features of hypertensive-diabetic heart muscle disease. Cardiology. 1987;74:28-34.
94. Grossman E, Shemesh J, Shamiss A, Thaler M, Carroll J, Rosenthal T. Left ventricular mass in diabetes-hypertension. Arch Intern Med. 1992;152: 1001-4.
95. Sahai A, Ganguly PK. Congestive heart failure in diabetes with hypertension may be due to uncoupling of the atrial natriuretic peptide receptor-effector system in the kidney basolateral membrane. Am Heart J. 1991;122(1 Pt 1):164-70.
96. Nagano N, Nagano M, Yo Y, Iiyama K, Higaki J, Mikami H, et al. Role of glucose intolerance in cardiac diastolic function in essential hypertension. Hypertension. 1994;23(6 Pt 2):1002-5.
97. Danielsen R. Factors contributing to left ventricular diastolic dysfunction in long-term type I diabetic subjects. Acta Med Scand. 1988;224:249-56.
98. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991;265:3255-64.
99. Implications of the systolic hypertension in the elderly program. The Systolic Hypertension in the Elderly Program Cooperative Research Group. Hypertension. 1993;21:335-43.
100. Davidoff F. Control, complications, confidence: the Regenstrief Conference on the risks and benefits of intensive management in NIDDM [Editorial]. Ann Intern Med. 1996;124(1 Pt 1):65-6.